MiR-551b-5p Contributes to Pathogenesis of Vein Graft Failure via Upregulating Early Growth Response-1 Expression

Background: Vein graft failure (VGF) is a serious complication of coronary artery bypass graft, although the mechanism remains unclear. The study aimed to investigate the effects of microRNAs (miRNAs) on the endothelial dysfunction involved in VGF. Methods: Human umbilical vein endothelial cells (HUVECs) were subjected to mechanical stretch stimulation to induce endothelial dysfunction. Genome-wide transcriptome profiling was performed using the Human miRNA OneArray® V4 (PhalanxBio Inc., San Diego, USA). The miRNA-messenger RNA (mRNA) network was investigated using gene ontology and Kyoto Encyclopedia of Genes and Genomes. The miR-551b-5p mimic and inhibitor were applied to regulate miR-551b-5p expression in the HUVECs. The 5-ethynyl-2’-deoxyuridine assay, polymerase chain reaction (PCR), and Western blotting (WB) were used to assess HUVECs proliferation, mRNA expression, and protein expression, respectively. The vein graft model was established in early growth response (Egr)-1 knockout (KO) mice and wide-type (WT) C57BL/6J mice for pathological and immunohistochemical analysis. Endothelial cells isolated from the veins of WT and Egr-1 KO mice were subjected to mechanical stretch stimulation; PCR and WB were conducted to confirm the regulatory effect of Egr-1 on Intercellular adhesion molecule (Icam-1). One-way analysis of variance and independent t-test were performed for data analysis. Results: Thirty-eight miRNAs were differentially expressed in HUVECs after mechanical stretch stimulation. The bioinformatics analysis revealed that Egr-1 might be involved in VGF and was a potential target gene of miR-551b-5p. The mechanical stretch stimulation increased miR-551b-5p expression by 2.93 ± 0.08 fold (t = 3.07, P < 0.05), compared with the normal HUVECs. Transfection with the miR-551b-5p mimic or inhibitor increased expression of miR-551b-5p by 793.1 ± 171.6 fold (t = 13.84, P < 0.001) or decreased by 26.3% ± 2.4% (t = 26.39, P < 0.05) in the HUVECs, respectively. HUVECs proliferation and EGR-1 mRNA expression were significantly suppressed by inhibiting miR-551b-5p expression (P < 0.05). The lumens of the vein grafts in the Egr-1 KO mice were wider than that in the WT mice. Icam-1 expression was suppressed significantly in the Egr-1 KO vein grafts (P < 0.05). Conclusions: Increased miR-551b-5p expression leads to endothelial dysfunction by upregulating Egr-1 expression. EGR-1 KO can improve the function of a grafted vein through suppressing Icam-1.

[1]  Robert J Anderson,et al.  Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. , 2004, Journal of the American College of Cardiology.

[2]  J. Pagel,et al.  Disease Progression Mediated by Egr-1 Associated Signaling in Response to Oxidative Stress , 2012, International journal of molecular sciences.

[3]  C. Brophy,et al.  Pressure control during preparation of saphenous veins. , 2014, JAMA surgery.

[4]  J. Gaughan,et al.  Early Growth Responsive Gene (Egr)-1 Expression Correlates with Cardiac Allograft Rejection , 2004, Transplantation.

[5]  Y. Suárez,et al.  MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. , 2013, Pharmacological research.

[6]  Seung‐Hyuk Choi,et al.  Early growth response factor-1 is associated with intraluminal thrombus formation in human abdominal aortic aneurysm. , 2009, Journal of the American College of Cardiology.

[7]  Y. Zou,et al.  Early Growth Response-1 Promotes Atherogenesis: Mice Deficient in Early Growth Response-1 and Apolipoprotein E Display Decreased Atherosclerosis and Vascular Inflammation , 2004, Circulation research.

[8]  J. Liao Linking endothelial dysfunction with endothelial cell activation. , 2013, The Journal of clinical investigation.

[9]  Jie Du,et al.  Early Growth Response Protein 1 Promotes Restenosis by Upregulating Intercellular Adhesion Molecule-1 in Vein Graft , 2013, Oxidative medicine and cellular longevity.

[10]  G. Garcı́a-Cardeña,et al.  Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  E. van Rooij,et al.  miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation , 2013, European heart journal.

[12]  Huijun Sun,et al.  Naringin inhibits TNF-α induced oxidative stress and inflammatory response in HUVECs via Nox4/NF-κ B and PI3K/Akt pathways. , 2014, Current pharmaceutical biotechnology.

[13]  J. Shalhoub,et al.  The Effect of Pressure-Induced Mechanical Stretch on Vascular Wall Differential Gene Expression , 2012, Journal of Vascular Research.

[14]  Shiro Tanaka,et al.  Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype. , 2014, The Journal of thoracic and cardiovascular surgery.

[15]  D. Pinsky,et al.  Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1) , 2002, Circulation research.

[16]  P. Most,et al.  MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1 , 2013, PloS one.

[17]  G. Angelini,et al.  Arterial blood pressure and vascular function in human saphenous vein , 2015, Perfusion.

[18]  M. Bourassa Fate of venous grafts: the past, the present and the future. , 1991, Journal of the American College of Cardiology.

[19]  D. Srivastava,et al.  The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. , 2014, Cell stem cell.

[20]  Shuzhen Chen,et al.  Effects of Endothelial Progenitor Cell-Derived Microvesicles on Hypoxia/Reoxygenation-Induced Endothelial Dysfunction and Apoptosis , 2013, Oxidative medicine and cellular longevity.

[21]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[22]  E. Stępień,et al.  Serum levels of unique miR-551-5p and endothelial-specific miR-126a-5p allow discrimination of patients in the early phase of acute pancreatitis. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[23]  C. Brophy,et al.  Intimal thickness associated with endothelial dysfunction in human vein grafts. , 2013, The Journal of surgical research.

[24]  Qingbo Xu,et al.  Mouse model of venous bypass graft arteriosclerosis. , 1998, The American journal of pathology.